Jubilee Life Insurance Company Limited (PSX:JLICL)
Pakistan · Delayed Price · Currency is PKR 229.40
-6.26 (-2.66%)
At close: Jan 30, 2026
PSX:JLICL Income Statement
Financials in millions PKR. Fiscal year is January - December.
Millions PKR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Premiums & Annuity Revenue | 54,345 | 46,563 | 44,086 | 45,571 | 47,580 | 45,208 |
Total Interest & Dividend Income | 26,315 | 35,279 | 30,714 | 19,080 | 12,275 | 12,025 |
Gain (Loss) on Sale of Investments | 23,167 | 18,321 | 2,774 | -14,737 | -8,309 | -387.87 |
Other Revenue | 403.51 | 629.75 | 616.34 | 333.68 | 216.75 | 280.44 |
| 104,230 | 100,792 | 78,190 | 50,248 | 51,762 | 57,125 | |
Revenue Growth (YoY) | 9.85% | 28.91% | 55.61% | -2.93% | -9.39% | -16.92% |
Policy Benefits | 85,318 | 82,766 | 61,716 | 35,833 | 38,306 | 42,377 |
Policy Acquisition & Underwriting Costs | 7,044 | 6,332 | 6,276 | 6,642 | 6,922 | 6,975 |
Selling, General & Administrative | 7,423 | 7,211 | 5,692 | 4,352 | 3,828 | 3,402 |
Other Operating Expenses | 30.9 | 31.69 | 42.36 | 44.22 | 61.41 | 49.67 |
Total Operating Expenses | 99,816 | 96,340 | 73,725 | 46,872 | 49,117 | 52,803 |
Operating Income | 4,413 | 4,452 | 4,465 | 3,377 | 2,646 | 4,322 |
Interest Expense | -152.94 | -203.28 | -191.43 | -130.92 | -144.98 | -283.14 |
Earnings From Equity Investments | 37.39 | 25.39 | 31.21 | 13.92 | 14.1 | 19.27 |
Currency Exchange Gain (Loss) | 17.55 | 17.55 | 12.46 | 13.96 | -8.81 | 0.37 |
EBT Excluding Unusual Items | 4,315 | 4,292 | 4,317 | 3,274 | 2,506 | 4,058 |
Gain (Loss) on Sale of Assets | 33.2 | 33.2 | 35.91 | 27.37 | 34.4 | 11.91 |
Pretax Income | 4,348 | 4,325 | 4,353 | 3,301 | 2,540 | 4,070 |
Income Tax Expense | 1,657 | 1,751 | 2,047 | 1,229 | 747.13 | 1,186 |
Net Income | 2,691 | 2,574 | 2,306 | 2,072 | 1,793 | 2,884 |
Net Income to Common | 2,691 | 2,574 | 2,306 | 2,072 | 1,793 | 2,884 |
Net Income Growth | 5.03% | 11.60% | 11.30% | 15.56% | -37.83% | 29.68% |
Shares Outstanding (Basic) | 100 | 100 | 100 | 100 | 100 | 100 |
Shares Outstanding (Diluted) | 100 | 100 | 100 | 100 | 100 | 100 |
Shares Change (YoY) | - | - | - | -0.00% | - | - |
EPS (Basic) | 26.82 | 25.65 | 22.98 | 20.65 | 17.87 | 28.74 |
EPS (Diluted) | 26.82 | 25.65 | 22.98 | 20.65 | 17.87 | 28.74 |
EPS Growth | 5.03% | 11.60% | 11.30% | 15.56% | -37.83% | 29.68% |
Free Cash Flow | -13,323 | -22,619 | -13,815 | -6,644 | -1,962 | 6,286 |
Free Cash Flow Per Share | -132.76 | -225.39 | -137.66 | -66.21 | -19.55 | 62.64 |
Dividend Per Share | 13.000 | 13.000 | 13.000 | 11.304 | 12.609 | 14.348 |
Dividend Growth | - | - | 15.00% | -10.35% | -12.12% | 10.00% |
Operating Margin | 4.23% | 4.42% | 5.71% | 6.72% | 5.11% | 7.56% |
Profit Margin | 2.58% | 2.55% | 2.95% | 4.12% | 3.46% | 5.05% |
Free Cash Flow Margin | -12.78% | -22.44% | -17.67% | -13.22% | -3.79% | 11.00% |
EBITDA | 4,762 | 4,785 | 4,833 | 3,788 | 3,025 | 4,654 |
EBITDA Margin | 4.57% | 4.75% | 6.18% | 7.54% | 5.84% | 8.15% |
D&A For EBITDA | 348.98 | 332.9 | 367.77 | 411.4 | 379.48 | 332.12 |
EBIT | 4,413 | 4,452 | 4,465 | 3,377 | 2,646 | 4,322 |
EBIT Margin | 4.23% | 4.42% | 5.71% | 6.72% | 5.11% | 7.56% |
Effective Tax Rate | 38.10% | 40.49% | 47.02% | 37.23% | 29.41% | 29.13% |
Revenue as Reported | 104,281 | 100,843 | 78,239 | 50,290 | 51,788 | 57,137 |
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.